Advertisement
Review Article| Volume 49, ISSUE 1, P43-53, March 2022

Counseling for Perinatal Outcomes in Women with Congenital Heart Disease

  • Jennifer F. Gerardin
    Affiliations
    Department of Internal Medicine, Division of Cardiovascular Medicine, Medical College of Wisconsin, 8915 W. Connell Ct, PO Box 1997, Milwaukee, WI 53226, USA

    Department of Pediatrics, Division of Pediatric Cardiology, Medical College of Wisconsin, 8915 W. Connell Ct, PO Box 1997, Milwaukee, WI 53226, USA
    Search for articles by this author
  • Scott Cohen
    Correspondence
    Corresponding author. Department of Internal Medicine, Division of Cardiovascular Medicine, Medical College of Wisconsin, 8915 W. Connell Ct, PO Box 1997, Milwaukee, WI 53226.
    Affiliations
    Department of Internal Medicine, Division of Cardiovascular Medicine, Medical College of Wisconsin, 8915 W. Connell Ct, PO Box 1997, Milwaukee, WI 53226, USA

    Department of Pediatrics, Division of Pediatric Cardiology, Medical College of Wisconsin, 8915 W. Connell Ct, PO Box 1997, Milwaukee, WI 53226, USA
    Search for articles by this author
Published:January 21, 2022DOI:https://doi.org/10.1016/j.clp.2021.11.004

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Perinatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gilboa S.M.
        • Devine O.J.
        • Kucik J.E.
        • et al.
        Congenital heart defects in the United States: estimating the magnitude of the affect population in 2010.
        Circulation. 2016; 134: 101-109
        • Canobbio M.M.
        • Warnes C.A.
        • Aboulhosn J.
        • et al.
        Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association.
        Circulation. 2017; 135: e50-e87
        • Bhatt A.B.
        • DeFaria Yeh D.
        Pregnancy and adult congenital heart disease.
        Cardiol Clin. 2015; 33: 611-623
        • Salam A.M.
        • Ertekin E.
        • van Hagen I.M.
        • et al.
        Atrial fibrillation or flutter during pregnancy in patients with structural heart disease: data from the ROPAC (Registry on Pregnancy and Cardiac Disease).
        JACC Clin Electrophysiol. 2015; 1: 284-292
        • Ertekin E.
        • van Hagen I.M.
        • Salam A.M.
        • et al.
        Ventricular tachyarrhythmia during pregnancy in women with heart disease: data from the ROPAC, a registry from the European Society of Cardiology.
        Int J Cardiol. 2016; 220: 131-136
        • Stout K.K.
        • Daniels C.J.
        • Aboulhosn J.A.
        • et al.
        2018 AHA/ACC Guideline for management of adults with congenital heart disease: executive summary.
        Circulation. 2019; 139: e637-e697
        • Ruys T.P.E.
        • Maggioni A.
        • Johnson M.R.
        • et al.
        Cardiac medication during pregnancy, data from ROPAC.
        Int J Cardiol. 2014; 177: 124-128
        • Rolnik D.L.
        • Nicolaides K.H.
        • Poon L.C.
        Prevention of preeclampsia with aspirin.
        Am J Obstet Gynecol. 2020; (S0002-9378(20)30873-5)
        • Battarbee A.N.
        • Sinkey R.G.
        • Harper L.M.
        • et al.
        Chronic hypertension in pregnancy.
        Am J Obstet Gynecol. 2020; 222: 532-541
        • Nishimura R.A.
        • Warnes C.A.
        Anticoagulation during pregnancy in women with prosthetic valves: evidence, guidelines and unanswered questions.
        Heart. 2015; 101: 430-435
        • Sachdeva R.
        • Valente A.M.
        • Armstrong A.K.
        • et al.
        ACC/AHA/ASE/HRS/ISACHD/SCAI/SCCT/SCMR/SOPE 2020 Appropriate use criteria for multimodality imaging during the follow up care of patients with congenital heart disease: a report of the American College of Cardiology solution set oversight committee and appropriate use criteria task force, American heart association, American society of echocardiography, Heart rhythm society, International Society for Adult Congenital Heart Disease, Society of cardiovascular angiography and interventions, Society of cardiovascular computed tomography, Society for cardiovascular magnetic resonance, and society of pediatric echocardiography.
        J Am Coll Cardiol. 2020; 75: 657-703
        • Pierpont M.E.
        • Brueckner M.
        • Chung W.K.
        • et al.
        Genetic basis for congenital heart disease revisited. A scientific statement from the American Heart Association.
        Circulation. 2018; 138: e653-e711
        • Chitra N.
        • Vijayalakshmi I.B.
        Fetal echocardiography for early detection of congenital heart diseases.
        J Echocardiogr. 2017; 15: 13-17
        • Martin G.R.
        • Ewer A.W.
        • Gaviglio A.
        • et al.
        Updated Strategies for pulse oximetry screening for critical congenital heart disease.
        Pediatrics. 2020; 146: 1-10
        • Sui S.C.
        • Sermer M.
        • Colman J.M.
        • et al.
        Prospective multicenter study of pregnancy outcomes in women with cardiac disease.
        Circulation. 2001; 104: 515-521
        • Silversides C.K.
        • Grewal J.
        • Mason J.
        • et al.
        Pregnancy outcomes in women with heart disease. The CARPREG II Study.
        J Am Coll Cardiol. 2018; 71: 2419-2430
        • Thorne S.
        • MacGregor A.
        • Nelson-Piercy C.
        Risks of contraception and pregnancy in heart disease.
        Heart. 2006; 92: 1520-1525
        • Drenthen W.
        • Boersma E.
        • Balci A.
        • et al.
        Predictors of pregnancy complications in women with congenital heart disease.
        Eur Heart J. 2010; 31: 2124-2132
        • Kim Y.Y.
        • Goldberg L.A.
        • Awh K.
        • et al.
        Accuracy of risk prediction scores in pregnant women with congenital heart disease.
        Congenit Heart Dis. 2019; 14: 470-478
        • Balci A.
        • Sollie-Szarynska K.M.
        • van der Bijl A.G.
        • et al.
        Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease.
        Heart. 2014; 100: 1373-1381
        • Krieger E.V.
        • Stout K.K.
        Progress: the ROPAC multinational registry advances our understanding of an important outcome in pregnant women with heart disease.
        Heart. 2014; 100: 188-189
        • Roos-Hesselink J.
        • Baris L.
        • Johnson M.
        • et al.
        Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry of pregnancy and cardiac disease (ROPAC).
        Eur Heart J. 2019; 40: 3848-3855
        • Van Hagen I.M.
        • Roos-Hesselink J.W.
        • Ruys T.P.
        • et al.
        Pregnancy in women with a mechanical heart valve: data of the European society of Cardiology registry of pregnancy and cardiac disease (ROPAC).
        Circulation. 2015; 132: 132-142
        • Orwat S.
        • Diller G.P.
        • van Hagen I.M.
        • et al.
        Risk of pregnancy in moderate and severe aortic stenosis: from the multinational ROPAC registry.
        J Am Coll Cardiol. 2016; 68: 1727-1737
        • Rychik J.
        • Atz A.M.
        • Celermajer D.S.
        • et al.
        Evaluation and management of child and adult with Fontan circulation: a scientific statement from the American heart association.
        Circulation. 2019; 140: e234-e284
        • D’Udekem Y.
        • Iyengar A.J.
        • Galati J.C.
        • et al.
        Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand.
        Circulation. 2014; 130: S32-S38
        • Book W.M.
        • Gerardin J.
        • Saraf A.
        • et al.
        Clinical phenotypes of fontan failure: implications for management.
        Congenit Heart Dis. 2016; 11: 296-308
        • Cauldwell M.
        • Steer P.J.
        • Bonner S.
        • et al.
        Retrospective UK multicenter study of the pregnancy outcomes of women with a Fontan repair.
        Heart. 2018; 104: 401-406
        • Afshar Y.
        • Tan W.
        • Jones W.M.
        • et al.
        Maternal Fontan procedure for gestational- age neonate: a 10-year retrospective study.
        Am J Obstet Gynecol. 2019; 1: 100036
        • Ginnius A.
        • Zentner D.
        • Valente A.M.
        • et al.
        Bleeding and thrombotic risk in pregnant women with Fontan physiology.
        Heart. 2020; 107: 1390-1397
        • Garcia Ropero A.
        • Baskar S.
        • Roos Hasselink J.W.
        • et al.
        Pregnancy in women with a fontan circulation: a systemic review of literature.
        Circ Cardiovasc Qual Outcomes. 2018; 11: e004575
        • Stout K.K.
        • Broberg C.S.
        • Book W.M.
        • et al.
        Chronic heart failure in congenital heart disese. A scientific statement from the American Heart Association.
        Circulation. 2016; 133: 770-801
        • Wolfe N.K.
        • Sabol B.A.
        • Kelly J.C.
        • et al.
        Management of Fontan circulation in pregnancy: a multidisciplinary approach to care.
        Am J Obstet Gynecol. 2021; 3: 100257
        • Gerardin J.F.
        • Earing M.G.
        Preoperative evaluation of adult congenital heart disease for non-cardiac surgery.
        Curr Cardiol Rep. 2018; 20: 76
        • Tutarel O.
        • Baris L.
        • Budts W.
        • et al.
        Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC).
        Heart. 2021; 0: 1-7
        • Ntiloudi D.
        • Giannakoulas G.
        Pregnancy still contraindicated in pulmonary arterial hypertension related to congenital heart disease: true or False?.
        Eur J Prev Cardiol. 2019; 26: 1064-1069
        • Ladouceur M.
        • Benoit L.
        • Radojevic J.
        • et al.
        Pregnancy outcomes in patients with pulmonary arterial hypertension associated with congenital heart disease.
        Heart. 2017; 103: 287-292
        • Li Q.
        • Dimopoulos K.
        • Liu T.
        • et al.
        Peripartum outcomes in a large population of women with pulmonary hypertension associated with congenital heart disease.
        Eur J Prev Cardiol. 2019; 26: 1067-1076
        • Sliwa K.
        • van Hagen I.M.
        • Budts W.
        • et al.
        Pulmonary hypertension and pregnancy outcomes: data from the pregnancy and cardiac disease (ROPAC) of the European society of Cardiology.
        Eur J Heart Fail. 2016; 18: 1119-1128
        • Campens L.
        • Baris L.
        • Scott N.S.
        • et al.
        Pregnancy outcome in thoracic aortic disease data from Registry of pregnancy and cardiac disease.
        Heart. 2021; 107: 1704-1709